教育背景
2006.9-2009.6华中科技大学药学院药理学博士;
1998.9-2001.6湖北中医药大学药物分析学硕士;
1992.7-1998.8湖北省中医院药剂科,药师;
1988.9-1992.7湖北中医药大学中药学学士。
工作经历
2009.11至今华中科技大学同济药学院,副教授;
2001.7-2009.10华中科技大学同济药学院,讲师;
2011.5-2012.5美国明尼苏达大学药学院博士后、访问学者;
项目课题经历
1.湖北省技术创新专项重大项目,2016ACA141,治疗2型糖尿病“消渴饮水”方中的中药复方组分候选药物研究,2016/09–2019/9,100万,主要参加。
2.基于纳米包覆的中药浸膏粉体改性技术研究。2015湖北省自然科学基金面上项目,2015.1-2016.12,主持。
3.“重大新药创制”科技重大专项“十二五”计划,2010-2013,285万,主要参加。
4.中药提取物粉体的新型包覆改性技术研究。华中科技大学自主创新基金,2015.1-2016.12,主持。
5.南方露珠草醇提物抗大鼠佐剂性关节炎作用及机制研究。华中科技大学大学生创新创业训练计划项目,2015.1-2015.12,主持。
6.多花落新妇中香豆素类成分对LPS诱导的RAW264.7细胞NLRP3及炎症因子分泌的影响研究,华中科技大学大学生创新创业训练计划项目,2017.1-2017.12,主持。
7.湖北福人药业委托项目,新药复方金刚藤胶囊临床前研究,2008/11- 2014/12,95万,主要参加。
8.湖北省环保科研项目,2016.1-2016.12,主持人,20万元。
9.烟叶组织形态与品质性状的相关性研究。2008年湖北省自然科学基金项目,2009.1-2010.12,主持人,33万元。
9.植烟土壤中有机氯农药残留量的气相色谱法测定。中国烟草标准化研究项目,2009.1-2010.6,主持人,13万元。
10.鄂产六种獐牙菜属植物抗糖尿病作用及资源品质研究。国家自然科学基金面上项目,2010.01-2012.12,主要参加。
11.烟叶组织形态学研究。横向、湖北省烟草科研所,2006.9-2008.9,主持人,24.95万。
12.道地药材湖北麦冬中均一多糖降血糖功能与结构研究。国家自然科学基金面上项目,2009.01-2011.12,主要参加。
论文、成果、著作等
1.Zhang Q, Yu Y, Li J,Qun Zhou*,et al. Anti-arthritic activities of ethanol extracts of Circaea mollis Sieb. & Zucc. (whole plant) in rodents. Journal of Ethnopharmacology, 2018.
2.Changxing Qi(#), Weixi Gao(#), Jianping Wang(#), Yongji Lai,Qun Zhou*,Hucheng Zhu*, Yonghui Zhang*.Terrusnolides A-D, new butenolides with anti-inflammatory activities from an endophyticAspergillusfromTripterygium wilfordii.Fitoterapia,2018,130:134–139.
3.Mengting Liu(#),Qun Zhou(#), Jianping Wang(#),Junjun Liu, Changxing Qi,Yongji Lai, Hucheng Zhu, Yongbo Xue, Zhengxi Hu *and Yonghui Zhang*.Anti-inflammatory butenolide derivatives from thecoral-derived fungusAspergillus terreusandstructure revisions of aspernolides D and G,butyrolactone VI and 4',8〞-diacetoxybutyrolactone VI.RSC Adv., 2018, 8, 13040-13047.
4.Chang-xing Qi(#),Qun Zhou(#), Yuan Zhou, Zeng-wei Luo, Chong Dai, Hu-cheng Zhu, Chun-mei Chen, Yong-bo Xue, Jian-ping Wang, Ya-fen Wang, Ya-ping Liu, Ming Xiang, Wei-guang Sun, Jin-wen Zhang*, Yong-hui Zhang*.Kinsenoside: A Promising Bioactive Compound from Anoectochilus Species.Current Medical Science,2018,38(1): 1-8.
5.Huaqiang Li(#), Weiguang Sun(#), Mengyi Deng(#),Qun Zhou, Jianping Wang, Junjun Liu, Chunmei Chen, Changxing Qi, Zengwei Luo, Yongbo Xue(*), Hucheng Zhu(*), andYonghui Zhang(*), Asperversiamides, Linearly Fused Prenylated Indole Alkaloids from the Marine-Derived Fungus Aspergillus versicolor, Journal of Organic Chemistry, 2018, 83, 8483−8492
6.Peng Zhou, Zhaodi Wu, Dongdong Tan, Jing Yang,Qun Zhou, Fanrong Zeng, Mi Zhang,Qiong Bie, Chunmei Chen, Yongbo Xue, Zengwei Luo, Jianping Wang*, Hucheng Zhu*,Yonghui Zhang*. Atrichodermones A–C, three new secondary metabolites from the solid culture of an endophytic fungal strain,Trichoderma atroviride.Fitoterapia. 2017, 123:18–22.
7.Xingchu Gong, Shao-Yu Chang, Frederick Osei-Yeboah, Shubhajit Paul,Sathyanarayana Reddy Perumalla, Limin Shi, Wei-Jhe Sun, Qun Zhou,Changquan Calvin Sun*.Dependence of tablet brittleness on tensile strength and porosity.International Journal of Pharmaceutics. 2015, 493:208-213.IF3.650.
8.Zhiping Wang, Junbiao Wu,Qun Zhou, Hua Fan, Yifei Wang, Tongsheng Chen.In Vitro and in Vivo Antitumor Efficacy of Curcumol Nanosuspension Against H22 Tumor.Advanced Materials ResearchVols,2014,998-999:151-155.
9.ZhipingWang,JunbiaoWu,Qun Zhou,YifeiWang,Tongsheng Chen, Berberine Nanosuspension Enhances Hypoglycemic Efficacy on Streptozotocin Induced Diabetic C57BL/6 Mice, Evidence-Based Complementary and Alternative Medicine, 2015, 2015:239749.
10.Zhiping Wang, Junbiao Wu,Qun Zhou, Hua Fan, Yifei Wang, Tongsheng Chen.In Vitro and in Vivo Antitumor Efficacy of Curcumol Nanosuspension Against H22 Tumor.Advanced Materials ResearchVols,2014,998-999:151-155.
11.Qun Zhou, Limin Shi, Sayantan Chattoraj, Changquan Calvin Sun. Preparation and characterization of surface-engineered coarse microcrystalline cellulose through drycoating with silica nanoparticles. Journal of Pharmaceutical Sciences.2012, 101(11):4258-4266. IF 3.13.
12.Qun Zhou*, Jingjing Wang, Beidi Meng, Junqi Cheng, Guoping Lin*,Dan Zhen, Jiachun Chen. Distribution and sources of organochlorine pesticides in agricultural soils from central China. Ecotoxicology and Environmental Safety, 2013,93:163-170. IF 2.482.
13.Jianqun Yuan, Limin Shi, Wei-Jhe Sun, Jiachun Chen,Qun Zhou*, Changquan Calvin Sun*. Enabling direct compression of formulated danshen powder by surface engineering. Powder technology, 2013, 241: 211-218. IF 2.269.
14.Qun Zhou, Limin Shi, William Marinaro, Qun Lu, Changquan Calvin Sun*. Improving manufacturability of an ibuprofen powder blend by surface coating with silica nanoparticles. Powder technology.2013, 249:290–296. IF 2.269.
15.王治平,周群,樊化,王一飞.口服葛根总黄酮纳米混悬液冻干粉的制备及其4种有效成分溶出度考察.中草药,2014, 45 (5): 635-641.
16.余艳宏,陆文亮,李佳佳,Changquan Calvin Sun,周群*,粉体表面改性技术改善中药浸膏粉流动性的研究.中国中药杂志,2014,39(23):4590-4595.
17.傅前霞,周群,王治平,樊化.葛根总黄酮纳米混悬液的制备及其降血糖作用研究.时珍国医国药,2014,25(11):2664-2666.
18.孟祥平,周群,王治平,樊化,王一飞.口服葛根总黄酮固体脂质纳米粒冻干粉的制备及其4种成分释放度考察.中草药,2014,45(17):2467-2474.
19.王治平,周群,樊化,王一飞. 口服葛根总黄酮纳米混悬液冻干粉的制备及其4种有效成分溶出度考察.中草药,2014,45(5):635-641.
专利、著作版权等
专利1:一种改善中药粉末流动性及压缩成型性的包衣方法。No. 201210451302.1排名1。
专利2:一种检测土壤中有机氯农药残留量的方法。申请公布号CN 102636603 A(43);申请号201110036752.X(22)。申请公布日2012.08.15。排名4。
声明:本站专家信息来源于各高校官网。